CCM
LLY icon

Copeland Capital Management’s Eli Lilly LLY Stock Holding History

Copeland Capital Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$17.2M Sell
18,730
-1,149
-6% -$1.16M 0.38% 96
2025
Q4 		$21.4M Sell
19,879
-1,023
-5% -$978K 0.48% 89
2025
Q3 		$15.9M Sell
20,902
-704
-3% -$524K 0.33% 103
2025
Q2 		$16.8M Sell
21,606
-76
-0.4% -$59.1K 0.35% 96
2025
Q1 		$17.9M Sell
21,682
-410
-2% -$341K 0.36% 94
2024
Q4 		$17.1M Sell
22,092
-3,277
-13% -$2.71M 0.32% 96
2024
Q3 		$22.5M Sell
25,369
-994
-4% -$894K 0.39% 92
2024
Q2 		$23.9M Buy
26,363
+886
+3% +$709K 0.45% 85
2024
Q1 		$19.8M Buy
25,477
+1,900
+8% +$1.35M 0.36% 87
2023
Q4 		$13.7M Buy
23,577
+9,318
+65% +$5.44M 0.28% 96
2023
Q3 		$7.66M Sell
14,259
-340
-2% -$175K 0.16% 112
2023
Q2 		$6.85M Buy
14,599
+13,217
+956% +$5.54M 0.14% 112
2023
Q1 		$475K Hold
1,382
– – 0.01% 129
2022
Q4 		$506K Hold
1,382
– – 0.01% 131
2022
Q3 		$447K Hold
1,382
– – 0.01% 129
2022
Q2 		$448K Hold
1,382
– – 0.01% 129
2022
Q1 		$396K Hold
1,382
– – 0.01% 126
2021
Q4 		$382K Hold
1,382
– – 0.01% 128
2021
Q3 		$319K Hold
1,382
– – 0.01% 131
2021
Q2 		$317K Hold
1,382
– – 0.01% 132
2021
Q1 		$258K Hold
1,382
– – 0.01% 135
2020
Q4 		$233K Hold
1,382
– – 0.01% 133
2020
Q3 		$205K Hold
1,382
– – 0.01% 123
2020
Q2 		$227K Hold
1,382
– – 0.01% 121
2020
Q1 		$192K Hold
1,382
– – 0.01% 124
2019
Q4 		$182K Hold
1,382
– – 0.01% 140
2019
Q3 		$155K Hold
1,382
– – 0.01% 138
2019
Q2 		$153K Hold
1,382
– – 0.01% 141
2019
Q1 		$179K Sell
1,382
-218
-14% -$26.5K 0.01% 134
2018
Q4 		$185K Buy
+1,600
New +$179K 0.01% 133

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Copeland Capital Management's LLY Position: Q1 2026 in Review

Copeland Capital Management reduced its Eli Lilly (LLY) stake by 5.8% in Q1 2026, selling an estimated $1.16M and leaving 18,730 shares worth $17.2M. The position accounts for 0.38% of the portfolio, ranked #96.

Copeland Capital Management first reported a position in LLY in Q4 2018 and has held it in 30 quarters since. The position peaked at $23.9M in Q2 2024. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Copeland Capital Management held 18,730 shares of Eli Lilly worth $17.2M as of Q1 2026.
  • Copeland Capital Management sold 1,149 Eli Lilly shares in Q1 2026, an estimated $1.16M.
  • Eli Lilly made up 0.38% of Copeland Capital Management's portfolio in Q1 2026, its #96 holding.
  • Copeland Capital Management first reported a position in Eli Lilly in Q4 2018 and has held it in 30 quarters since.
  • Copeland Capital Management's Eli Lilly position peaked at $23.9M in Q2 2024.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Copeland Capital Management's 13F filing for Q1 2026, filed 6 May 2026.